His research focuses on the molecular basis of animal physiology and behavior.
He Liu, Ph.D., is an assistant professor of biology at Gannon University. His research focuses on the molecular basis of animal physiology and behavior.
California South University
Biophysical Chemistry; Biomolecular Spectroscopy; Quantum Chemistry; Nanochemistry; Theoretical Chemistry; Mathematical Chemistry; Computational Chemistry; Vibrational Spectroscopy; Molecular Modelling; Ab initio & Density Functional Methods; Molecular Structure
Dr. Alireza Heidari, Ph.D., D.Sc. is a Postdoctoral Research Fellow in Chemistry. He has got his Ph.D. and D.Sc. degrees form California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management and also in Nanochemistry and Molecular Structure Theory. His research interests are Biophysical Chemistry, Nanochemistry, Quantum Chemistry, Biomolecular and Vibrational Spectroscopy, Molecular Modeling and Structure, Theoretical, Computational and Mathematical Chemistry, Ab initio and Density Functional Methods. He has participated at more than fifty reputed international conferences, seminars, congresses, symposiums and forums around the world as yet. Also, he possesses many published articles in Science Citation Index (SCI)/International Scientific Indexing (ISI) Journals.
University of Pennsylvania School of Medicine
Targeting cancers with specific and combined gene therapy and viro-therapy Gene-virotherapy is a combination of gene therapy and virotherapy, utilizing therapeutic gene armed oncolytic adenoviruses to target cancer cells. The oncolytic adenoviruses could specially replicate in cancer cells and directly lyze the cancer cells. The armed therapeutic genes could replicate together with the viruses and high expressed in the cancer cells. This combination makes the gene-viruses exhibit specially and potently anticancer effect in vitro and in vivo. We constructed the oncolytic adenovirus with antitumor genes acetylcholinesterase (AChE), hepatocellular carcinoma suppressor 1 (HCCS1) or TRAIL and tested their efficiency and specificity in cancer therapy. Human patients samples, cancer cell lines, primary fibroblast cells, primary epithelial cells and xenografts on nude mice were used in these studies. Oncolytic adenoviruses with therapeutic genes showed great efficiency in inhibiting gastric cancer, specific targeting liver cancer or eliminating lung cancer stem cells. These provided new approaches for cancer therapy.
University of Michigan Medical School
Epigenetic regulation mediated by long non-coding RNAs and Histone modifiers in development and disease
Pauline Po Yee Lui
Biological research on tendinopathy; ACL reconstruction; tendon healing; tissue engineering; tendon-derived stem cells (TDSCs)
Dr. Pauline Po-Yee LUI graduated from the Department of Biochemistry, The Chinese University of Hong Kong, with first-class honor. She then furthered her PhD study in the same department. She also has a PgCert in Pharmacology and Pharmaceutical Management and a PgDip in Clinical Trial Research Methodology, The University of Hong Kong. Dr. LUI is currently the Scientific Grant Reviewer of the Research Office in the Hospital Authority, Hong Kong SAR. She was previously the associate professor of the Department of Orthopaedics and Traumatology, The Chinese University of Hong Kong. Her research interest includes tendon stem cells and their niches, tissue engineering and regenerative medicine, sports medicine particularly on the pathogenesis and treatment of tendinopathy, anterior cruciate ligament reconstruction and tendon healing. She has published over 70 peer-reviewed papers and is the holder of two patents. She has been the reviewer for 48 journals
Lorenzo Lo Muzio
Università degli studi di Foggia
Head and Neck Cancer and Precancerous Conditions, Oral Immunopathology and Infection, Stem Cell Biology and Its Application
Dr. Lorenzo Lo Muzio is a Professor of Oral Pathology and Medicine at the University of Foggia in Italy, and director of Clinical and Experimental Medicine Department in University of Foggia, Italy. He has successfully completed his PhD at Sun University, Italy in 1996. Also, he completed his Postdoctoral fellowship in the University of Naples, Italy. He worked as Professor at DU of Dental Igienist at University of Bari from 1998-2000, he worked as Associate professor at Università Politecnica delle Marche- Ancona from 2000-2004. He is the President of Corso di Laurea in Odontoiatria e Protesi Dentaria at the University of Foggia from 2005 to date. He is the president of SIPMO and Vice-Director of CINBO. His research interests cover several fields of oral pathology with a special interest in oral oncogenesis (apoptosis, cell-cell adhesion, cancer stem cell) and auto immunitary diseases of the oral mucosa. He received several grants for his researches on oral oncology. In 2003 he participated to COST Action B23 “Facing Challenges in Oral Facial Development” - VI Framework in the Working Group “Stem cells and hard tissue formation”. He has published 800 scientific papers, posters, abstracts; about 400 are MEDLINE papers (total IF is about 900, about 8.000 citations, 46 H-index).
University of Chieti-Pescara
Hangzhou Normal University
Genetic Regulations of Craniofacial Development
University of Uruguay
National Institute of Genetic Engineering and Biotechnology
Protein modeling; Molecular Dynamics simulation; protein-protein interaction; protein ligand interaction; engineering thermal stability and catalytic activity of proteins following laboratory study; Gene cloning and expression following protein purification
Ahmad R. Safa
Indiana University Cancer Research Institute
Sushma Bohra Rathaur
Banaras Hindu University
Filarial Immunobiology, Molecular Biology
Nuclear Medicine, Radiation Biophysics, Cancer Research